Genome editing HLA alleles for a pilot immunocompatible hESC line in a Chinese hESC bank for cell therapies.
Ji TT, Niu SS, Fang MH, Xu LX, Wang X, Zou J, Xu F, Zhang M, Niu R, Wu J, Wang L, Li ZK, Yang YG, Hao J, Li W, Hu Z, Zhou Q.
Ji TT, et al.
Cell Prolif. 2023 May;56(5):e13471. doi: 10.1111/cpr.13471. Epub 2023 May 17.
Cell Prolif. 2023.
PMID: 37199039
Free PMC article.